NeuroOne Medical Technologies Corporation
Last updated September 27, 2026
Organization details
- Legal name
- NeuroOne Medical Technologies Corporation
- Former names
- Original Source Entertainment, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Eden Prairie
- Headquarters state / province
- Minnesota
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- NMTC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001500198
- EIN
- 27-0863354
Board of directors
-
David A. Rosa · Director · CEO & PresidentSince 2023
-
Edward Andrle · DirectorSince 2023
-
Jason Richard Mills · DirectorSince 2025
-
Jeffrey S. Mathiesen · DirectorSince 2023
-
Paul Buckman · DirectorSince 2023
Chief executives
David A. Rosa
· CEO and President
Dates unknown
Director election results
Annual meeting of April 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.3%
-
97.4%
Board connections
3 of this board's directors also sit on 4 other boards.
- via Jeffrey S. Mathiesen and Paul Buckman
- via David A. Rosa
- via David A. Rosa
- via Paul Buckman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $736,999
- 2 purchases by 1 insider
- Sold, last 12 months
- $54,851
- 6 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 27, 2026 | Wambeke David J. Officer (Chief Business Officer) | Open-market purchase | +33,333 | $2.01 | $66,999 |
| Jun 30, 2026 | Christianson Mark Officer (Market Development Director) | Open-market sale | −10,000 | $3.18 | $31,773 |
| Apr 3, 2026 | Jason Richard Mills Director | Grant or award | +41,929 | — | — |
| Apr 3, 2026 | Jeffrey S. Mathiesen Director | Grant or award | +41,929 | — | — |
| Apr 3, 2026 | Paul Buckman Director | Grant or award | +41,929 | — | — |
| Apr 3, 2026 | Edward Andrle Director | Grant or award | +41,929 | — | — |
| Mar 31, 2026 | Mertens Steve Officer (Chief Technology Officer) | Shares withheld for tax | −906 | $0.78 | $707 |
| Mar 31, 2026 | David A. Rosa Director, Officer (CEO and President) | Shares withheld for tax | −2,458 | $0.78 | $1,917 |
| Mar 31, 2026 | Christianson Mark Officer (Business Development Director) | Shares withheld for tax | −253 | $0.78 | $197 |
| Mar 30, 2026 | Christianson Mark Officer (Business Development Director) | Open-market sale | −15,363 | $0.74 | $11,369 |
| Mar 13, 2026 | Christianson Mark Officer (Business Development Director) | Open-market sale | −100 | $0.80 | $80 |
| Mar 12, 2026 | Christianson Mark Officer (Business Development Director) | Open-market sale | −817 | $0.80 | $654 |
| Mar 11, 2026 | Christianson Mark Officer (Business Development Director) | Open-market sale | −2,109 | $0.80 | $1,687 |
| Mar 10, 2026 | Christianson Mark Officer (Business Development Director) | Open-market sale | −11,611 | $0.80 | $9,289 |
| Mar 1, 2026 | Wambeke David J. Officer (Chief Business Officer) | Open-market purchase | +1,000,000 | $0.67 | $670,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.